Researchers identified schizophrenia risk genes that mediate placental, rather than brain, function, revealing new insight into the disease’s developmental origins.
Psychedelics like psilocybin, DMT, and LSD are increasingly welcomed in behavioural and psychiatric research, with implications that extend well beyond neuroscience. This webinar will delve into efforts to transform anecdotal evidence into supported medical interventions through systematic research and controlled clinical trials.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.